{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:06:35Z","timestamp":1793862395688,"version":"4.6.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/qco.0000000000000090","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T16:38:47Z","timestamp":1405442327000},"page":"403-410","source":"Crossref","is-referenced-by-count":68,"title":["Complications of tuberculosis"],"prefix":"10.1097","volume":"27","author":[{"given":"Maunank","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.","volume":"163","author":"Corbett","year":"2003","journal-title":"Arc Intern Med"},{"key":"R6-2-20210205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S1806-37132010000500017","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs.","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"key":"R7-2-20210205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs.","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"key":"R8-2-20210205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs.","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"R9-2-20210205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrgastro.2010.134","article-title":"Hepatotoxic effects of therapies for tuberculosis.","volume":"7","author":"Senousy","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-2-20210205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5588\/ijtld.13.0901","article-title":"Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country.","volume":"18","author":"Lanoix","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"R11-2-20210205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2334-12-121","article-title":"Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China.","volume":"12","author":"Deng","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R12-2-20210205","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.10.0557","article-title":"Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea.","volume":"15","author":"Lee","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R13-2-20210205","first-page":"429","article-title":"Predictors of development and outcome in patients with acute respiratory distress syndrome due to tuberculosis.","volume":"10","author":"Sharma","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R14-2-20210205","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.12-1286","article-title":"Mycobacterium tuberculosis septic shock.","volume":"144","author":"Kethireddy","year":"2013","journal-title":"Chest"},{"key":"R15-2-20210205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1183\/09031936.00070907","article-title":"Pulmonary tuberculosis with acute respiratory failure.","volume":"32","author":"Kim","year":"2008","journal-title":"Eur Respir J"},{"key":"R16-2-20210205","doi-asserted-by":"crossref","first-page":"e70305","DOI":"10.1371\/journal.pone.0070305","article-title":"Mycobacterium tuberculosis bacteremia in a cohort of HIV-infected patients hospitalized with severe sepsis in Uganda-high frequency, low clinical sand derivation of a clinical prediction score.","volume":"8","author":"Jacob","year":"2013","journal-title":"PLoS One"},{"key":"R17-2-20210205","first-page":"CD009593","article-title":"Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.","volume":"1","author":"Steingart","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-2-20210205","first-page":"821","article-title":"Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013.","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-2-20210205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QAI.0b013e3181b98430","article-title":"Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting.","volume":"52","author":"Shah","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-2-20210205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-12-103","article-title":"Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.","volume":"12","author":"Lawn","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R22-2-20210205","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JCM.00363-10","article-title":"Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.","volume":"48","author":"Shah","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R23-2-20210205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2334-13-407","article-title":"Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies.","volume":"13","author":"Lawn","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R24-2-20210205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1741-7015-11-231","article-title":"HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.","volume":"11","author":"Lawn","year":"2013","journal-title":"BMC Med"},{"key":"R25-2-20210205","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/QAD.0000000000000264","article-title":"Comparative performance of urinary lipoarabinomannan assays and Xpert MTBRIF in HIV-infected individuals with suspected tuberculosis in Uganda.","volume":"28","author":"Shah","year":"2014","journal-title":"AIDS"},{"key":"R26-2-20210205","first-page":"1","article-title":"Society, CDC, Infectious Diseases Society of AmericaTreatment of tuberculosis.","volume":"52","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"R27-2-20210205","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.","volume":"47","author":"Jayaram","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-2-20210205","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/AAC.01474-06","article-title":"Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.","volume":"51","author":"Diacon","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-2-20210205","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/COH.0000000000000009","article-title":"Pipeline of drugs for related diseases: tuberculosis.","volume":"8","author":"Dooley","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"R30-2-20210205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R31-2-20210205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.","volume":"169","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-2-20210205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","article-title":"Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.","volume":"180","author":"Dorman","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-2-20210205","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.","volume":"373","author":"Conde","year":"2009","journal-title":"Lancet"},{"key":"R34-2-20210205","first-page":"128","article-title":"A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R35-2-20210205","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/500459","article-title":"Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients.","volume":"42","author":"Carvalho","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R36-2-20210205","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/429317","article-title":"Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis.","volume":"40","author":"Hawkey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R37-2-20210205","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes.","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R38-2-20210205","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"R39-2-20210205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis.","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R40-2-20210205","first-page":"47","article-title":"Prednisolone: a beneficial and safe adjunct to antituberculosis treatment A randomized controlled trial.","volume":"3","author":"Bilaceroglu","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"R41-2-20210205","first-page":"208","article-title":"A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis.","volume":"7","author":"Smego","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"R42-2-20210205","first-page":"229","article-title":"Centers for Disease Control and Prevention (CDC)Trends in tuberculosis - United States, 2013.","volume":"63","author":"Alami","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R43-2-20210205","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1378\/chest.126.6.1722","article-title":"Use of therapeutic drug monitoring in tuberculosis patients.","volume":"126","author":"Peloquin","year":"2004","journal-title":"Chest"},{"key":"R44-2-20210205","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3201\/eid1610.100374","article-title":"Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.","volume":"16","author":"Heysell","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R45-2-20210205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(09)70282-8","article-title":"Tuberculosis and diabetes mellitus: convergence of two epidemics.","volume":"9","author":"Dooley","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R46-2-20210205","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","article-title":"Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.","volume":"80","author":"Dooley","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"R47-2-20210205","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01124-13","article-title":"Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine.","volume":"57","author":"Williamson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-2-20210205","first-page":"1","article-title":"MMWR Recomm R","volume":"62","year":"2013","journal-title":"ep"},{"key":"R51-2-20210205","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis.","volume":"367","author":"Lee","year":"2012","journal-title":"N Engl J Med"},{"key":"R52-2-20210205","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.","volume":"40","author":"Sotgiu","year":"2012","journal-title":"Eur Respir J"},{"key":"R53-2-20210205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","article-title":"Linezolid in the treatment of multidrug-resistant tuberculosis.","volume":"50","author":"Schecter","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R54-2-20210205","first-page":"705","article-title":"Successful embolization of Rasmussens aneurysm for severe haemoptysis.","volume":"134","author":"Jayet","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"R55-2-20210205","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1148\/radiology.193.2.7972750","article-title":"Embolization of multiple Rasmussen aneurysms as a treatment of hemoptysis.","volume":"193","author":"Santelli","year":"1994","journal-title":"Radiology"},{"key":"R56-2-20210205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1148\/radiology.200.3.8756916","article-title":"Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization.","volume":"200","author":"Ramakantan","year":"1996","journal-title":"Radiology"},{"key":"R57-2-20210205","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","article-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006.","volume":"49","author":"Peto","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R59-2-20210205","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1474-4422(13)70168-6","article-title":"Tuberculous meningitis: more questions, still too few answers.","volume":"12","author":"Thwaites","year":"2013","journal-title":"Lancet Neurol"},{"key":"R60-2-20210205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(07)70034-0","article-title":"Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.","volume":"6","author":"Thwaites","year":"2007","journal-title":"Lancet Neurol"},{"key":"R61-2-20210205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pcad.2007.03.002","article-title":"A modern approach to tuberculous pericarditis.","volume":"50","author":"Syed","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"R63-2-20210205","first-page":"1959","article-title":"A practical approach to hypercalcemia.","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"key":"R64-2-20210205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.200804-567OC","article-title":"Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.","volume":"179","author":"Wejse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R65-2-20210205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-13-22","article-title":"Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study Supplementary Cholecalciferol in recovery from tuberculosis. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis.","volume":"13","author":"Salahuddin","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R66-2-20210205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5588\/ijtld.11.0368","article-title":"Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.","volume":"16","author":"Lavender","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R67-2-20210205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"R68-2-20210205","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.","volume":"365","author":"Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"R69-2-20210205","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.","volume":"365","author":"Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"R70-2-20210205","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment.","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"R72-2-20210205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.","volume":"10","author":"Muller","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R73-2-20210205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11904-012-0129-5","article-title":"Management of the immune reconstitution inflammatory syndrome.","volume":"9","author":"Meintjes","year":"2012","journal-title":"Curr HIVAIDS Rep"},{"key":"R74-2-20210205","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"R75-2-20210205","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/AAC.01468-08","article-title":"Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.","volume":"53","author":"Wenning","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R76-2-20210205","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/444545","article-title":"Lung remodeling in pulmonary tuberculosis.","volume":"192","author":"Dheda","year":"2005","journal-title":"J Infect Dis"},{"key":"R77-2-20210205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jiph.2011.08.005","article-title":"Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis.","volume":"4","author":"Vecino","year":"2011","journal-title":"J Infect Public Health"},{"key":"R78-2-20210205","first-page":"379","article-title":"Lung mechanics in pulmonary tuberculosis. 3. Bronchial reactivity.","volume":"54","author":"Skoogh","year":"1973","journal-title":"Scand J Respir Dis"},{"key":"R79-2-20210205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000192975","article-title":"Ventilation and transfer of gases in pulmonary tuberculosis.","volume":"30","author":"Lopez-Majano","year":"1973","journal-title":"Respiration"},{"key":"R80-2-20210205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0954-6111(89)80031-9","article-title":"Chronic obstructive airways disease following treated pulmonary tuberculosis.","volume":"83","author":"Willcox","year":"1989","journal-title":"Respir Med"},{"key":"R81-2-20210205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment.","volume":"55","author":"Hnizdo","year":"2000","journal-title":"Thorax"},{"key":"R82-2-20210205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.thorsurg.2012.05.006","article-title":"Surgery for the sequelae of postprimary tuberculosis.","volume":"22","author":"Massard","year":"2012","journal-title":"Thorac Surg Clin"},{"key":"R83-2-20210205","first-page":"82","article-title":"The destroyed tuberculous lung.","volume":"55","author":"Bobrowitz","year":"1974","journal-title":"Scand J Respir Dis"},{"key":"R84-2-20210205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1752-1947-7-40","article-title":"Postpneumonectomy-like syndrome presenting in a patient with treated pulmonary tuberculosis: a case report.","volume":"7","author":"Kam","year":"2013","journal-title":"J Med Case Rep"},{"key":"R85-2-20210205","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jtcvs.2007.12.035","article-title":"Surgical correction of postpneumonectomy-like syndrome in a patient with a tuberculosis-destroyed lung.","volume":"136","author":"Lee","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R86-2-20210205","first-page":"246","article-title":"Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung.","volume":"15","author":"Ryu","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R87-2-20210205","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10096-011-1205-2","article-title":"Endobronchial tuberculosis: an overview.","volume":"30","author":"Xue","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R88-2-20210205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0041-3879(70)90015-2","article-title":"T.T.A. British Thoracic and TB AssociationAspergilloma and residual tuberculous cavities - the results of a resurvey.","volume":"51","year":"1970","journal-title":"Tubercle"},{"key":"R89-2-20210205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archinte.1983.00350020129023","article-title":"Pulmonary aspergilloma. Diagnostic and therapeutic considerations.","volume":"143","author":"Glimp","year":"1983","journal-title":"Arch Intern Med"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0000000000000090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:05:48Z","timestamp":1620972348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201410000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000090","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}